Understanding drug resistance mechanisms in cholangiocarcinoma: assisting the clinical development of investigational drugs
José J.G. Marı́n, Rocı́o I.R. Macı́as
Abstract
KEYWORDS: Biliary tract cancerimmunotherapyliver cancerpharmacoresistancetargeted therapydrug resistancecholangiocarcinomaFGFRtumor heterogeneity
Topics & Concepts
Investigational DrugsDrug developmentDrugMedicineDrug resistancePharmacologyBiliary tractIntensive care medicineClinical trialBioinformaticsInternal medicineBiologyGeneticsCholangiocarcinoma and Gallbladder Cancer StudiesGallbladder and Bile Duct DisordersPeptidase Inhibition and Analysis